Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Limitations to air free cooling in data centers under rising heat and humidity.

Scientific reports·2026
Same author

Telmisartan reduces systemic inflammation and alters the renin-angiotensin system in mild COVID-19.

Scientific reports·2025
Same author

Lymphoid B cells upregulate HIV-1 ex vivo and are linked to its expression in vivo.

PLoS pathogens·2025
Same author

Dysregulation of complement components associated with inflammation and coagulation in virally suppressed people living with HIV.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

Peripheral immune progression to long COVID is associated with mitochondrial gene transcription: A meta-analysis.

Mitochondrion·2025
Same author

Science Speed Dating to Spur Inter-Institutional Collaborative Research.

International journal of environmental research and public health·2025

Related Experiment Video

Updated: Aug 26, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

42.9K

Dynamic SARS-CoV-2 emergence algorithm for rationally-designed logical next-generation vaccines.

David P Maison1,2,3, Lauren L Ching1,2,3, Sean B Cleveland4,5

  • 1Department of Tropical Medicine, Medical Microbiology, and Pharmacology, University of Hawai'i at Mānoa, Honolulu, HI, USA.

Communications Biology
|October 10, 2022
PubMed
Summary

The study developed an algorithm to track SARS-CoV-2 evolution and spike mutations, aiding in the design of next-generation vaccines and monitoring antibody efficacy against emerging variants.

More Related Videos

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

4.7K
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

599

Related Experiment Videos

Last Updated: Aug 26, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

42.9K
Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

4.7K
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

599

Area of Science:

  • Virology
  • Genomics
  • Immunology

Background:

  • Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) variants with immune-evasive mutations reduce vaccine effectiveness.
  • Monitoring viral evolution is crucial for public health interventions and therapeutic development.

Purpose of the Study:

  • To develop an algorithm for monitoring SARS-CoV-2 evolution, focusing on spike protein mutations.
  • To assess the correlation between viral mutations, prevalence, and potential impact on vaccines and monoclonal antibodies.

Main Methods:

  • Analysis of SARS-CoV-2 positive clinical samples to identify spike protein mutations.
  • Development of an algorithm using logarithmic-transformed prevalence data and Pearson's correlation to track amino acid substitutions (AAS) and lineages.
  • Evaluation of genome data to identify prevalent mutations and their correlation coefficients.

Main Results:

  • Identified 49 mutations in the SARS-CoV-2 genome, with 44 resulting in AAS.
  • Nine of the ten most prevalent spike protein mutations (>70%) showed a strong positive correlation (r > 0.9).
  • The D614G mutation, with >99% prevalence, had an r-value of 0.67, informing the algorithm's predictive value.

Conclusions:

  • The developed algorithm effectively monitors SARS-CoV-2 evolution and spike protein changes.
  • The correlation between mutations and prevalence can inform the design of more effective vaccines with relevant immunogenic epitopes.
  • Continuous monitoring and next-generation vaccine design are essential to combat the endemic SARS-CoV-2 and maintain monoclonal antibody efficacy.